2013
Preoperative chemoradiation and IOERT for unresectable or borderline resectable pancreas cancer
Ashman JB, Moss AA, Rule WG, Callister MG, Reddy KS, Mulligan DC, Collins JM, De Petris G, Gunderson LL, Borad M. Preoperative chemoradiation and IOERT for unresectable or borderline resectable pancreas cancer. Journal Of Gastrointestinal Oncology 2013, 4: 352-60. PMID: 24294506, PMCID: PMC3819779, DOI: 10.3978/j.issn.2078-6891.2013.006.Peer-Reviewed Original ResearchIntraoperative electron irradiationBorderline resectable pancreas cancerPreop-CRTGross total resectionResectable pancreas cancerPancreas cancerResection statusSurgical resectionTotal resectionCurative-intent surgical resectionPost-operative systemic chemotherapySubsequent gross total resectionAdvanced pancreatic ductal adenocarcinomaGross total surgical resectionDisease controlGemcitabine-based regimensPre-operative chemoradiationUnresectable pancreas cancerPatterns of relapseTotal surgical resectionHigh-risk populationPancreatic ductal adenocarcinomaLong-term survivalPeritoneal relapsePreoperative chemoradiation
2012
Neoadjuvant chemoradiation and intraoperative electron irradiation for locally unresectable/borderline resectable pancreas adenocarcinoma.
Ashman J, Moss A, Callister M, Reddy K, Mulligan D, Gunderson L, Borad M. Neoadjuvant chemoradiation and intraoperative electron irradiation for locally unresectable/borderline resectable pancreas adenocarcinoma. Journal Of Clinical Oncology 2012, 30: 327-327. DOI: 10.1200/jco.2012.30.4_suppl.327.Peer-Reviewed Original ResearchIntraoperative electron irradiationOverall survivalNeoadjuvant chemotherapyNeoadjuvant therapyPancreas adenocarcinomaPancreatic cancerKaplan-Meier survival analysisThree-year OSAdvanced pancreatic cancerMedian overall survivalNovel systemic agentsLog-rank testCurative surgeryR1 patientsR1 resectionDistant diseaseLocal progressionNeoadjuvant chemoradiationPreoperative therapyMedian survivalResection statusSurgical resectionSystemic agentsComplete resectionLocal therapy